StockData
Merck & Co., Inc. logo

Merck & Co., Inc.

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$149.52+3.19 (+2.18%)

Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%

Merck Non-GAAP Other (Income) Expense, Net by Quarter

Non-GAAP Other (Income) Expense, Net ($M) ($M)

QuarterlyAnnual

Merck Non-GAAP Other (Income) Expense, Net: $290M in Q2 2026.

Latest, Q2 2026
290
Period ended Jun 30, 2026
Change on a year earlier
–
History
28 quarters
Since Q4 2016
Sources
26
Documents cited below

Where the Q2 2026 figure comes from

“|| Other (income) expense, net | 99 | (191 | ) | (191 | ) | 290”

Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗

Reported in Form 8-K Table 2a.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP Other (Income) Expense, Net ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026290–Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Q1 2026Mar 31, 2026318–Form 8-K (tm2612241d1_ex99-1.htm, filed 2026-04-30) ↗
Q4 2025Dec 31, 2025226+4,420.0%Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Q4 2024Dec 31, 20245-97.1%Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Q3 2024Sep 30, 202431-76.7%Form 8-K (tm2529620d1_ex99-1.htm, filed 2025-10-30) ↗
Q2 2024Jun 30, 2024108-43.5%Form 8-K (tm2521736d1_ex99-1.htm, filed 2025-07-29) ↗
Q4 2023Dec 31, 2023174+1,481.8%Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗
Q3 2023Sep 30, 2023133+26.7%Form 8-K (tm2426878d1_ex99-1.htm, filed 2024-10-31) ↗
Q2 2023Jun 30, 2023191-5.4%Form 8-K (tm2420272d1_ex99-1.htm, filed 2024-07-30) ↗
Q1 2023Mar 31, 2023159+14.4%Form 8-K (tm2412490d1_ex99-1.htm, filed 2024-04-25) ↗
Q4 2022Dec 31, 202211–Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗
Q3 2022Sep 30, 2022105–Form 8-K (tm2328962d1_ex99-1.htm, filed 2023-10-26) ↗
Q2 2022Jun 30, 2022202+431.6%Form 8-K (tm2221828d1_ex99-1.htm, filed 2022-07-28) ↗
Q1 2022Mar 31, 2022139–Form 8-K (tm2213615d1_ex99-1.htm, filed 2022-04-28) ↗
Q2 2021Jun 30, 202138-50.6%Form 8-K (tm2221828d1_ex99-1.htm, filed 2022-07-28) ↗
Q2 2020Jun 30, 202077+113.9%Form 8-K (tm2123400d1_ex99-1.htm, filed 2021-07-29) ↗

Cite this data

StockData. (2026). Merck Non-GAAP Other (Income) Expense, Net ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/nongaap-other-inc-exp

See every metric in the Merck KPI table. Data updated Oct 26, 2026.